Our previous study demonstrated that APG-1387 exhibited dual antitumor effects on PLC/PRF/5 hepatoma cells, not only directly inducing tumor cell apoptosis through the caspase pathway but also enhancing innate antitumor immunity by upregulating CD45 + NK1.1 cells [16]. This evidence concerns the gene PTPRC and neoplasm.